| Literature DB >> 30510222 |
Zhao-Shan Liu1,2, Hong Cai2, Wen Xue2, Miao Wang2, Tian Xia2, Wan-Jin Li2, Jia-Qing Xing2, Ming Zhao2, Yi-Jiao Huang2, Shuai Chen2, Sheng-Ming Wu2, Xinzheng Wang2, Xin Liu2, Xue Pang2, Zi-Yu Zhang2, Tingting Li2, Jiang Dai1,2, Fangting Dong2, Qing Xia2, Ai-Ling Li2, Tao Zhou2, Zheng-Gang Liu3, Xue-Min Zhang4,5,6, Tao Li7,8,9.
Abstract
Cyclic GMP-AMP synthase (cGAS) is a key sensor responsible for cytosolic DNA detection. Here we report that GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) is critical for DNA sensing and efficient activation of cGAS. G3BP1 enhanced DNA binding of cGAS by promoting the formation of large cGAS complexes. G3BP1 deficiency led to inefficient DNA binding by cGAS and inhibited cGAS-dependent interferon (IFN) production. The G3BP1 inhibitor epigallocatechin gallate (EGCG) disrupted existing G3BP1-cGAS complexes and inhibited DNA-triggered cGAS activation, thereby blocking DNA-induced IFN production both in vivo and in vitro. EGCG administration blunted self DNA-induced autoinflammatory responses in an Aicardi-Goutières syndrome (AGS) mouse model and reduced IFN-stimulated gene expression in cells from a patient with AGS. Thus, our study reveals that G3BP1 physically interacts with and primes cGAS for efficient activation. Furthermore, EGCG-mediated inhibition of G3BP1 provides a potential treatment for cGAS-related autoimmune diseases.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30510222 PMCID: PMC8276115 DOI: 10.1038/s41590-018-0262-4
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606